Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Total 13F shares
-
142,604,810
-
Share change
-
+3,228,790
-
Total reported value
-
$1,186,537,769
-
Put/Call ratio
-
86%
-
Price per share
-
$8.32
-
Number of holders
-
180
-
Value change
-
+$32,197,946
-
Number of buys
-
87
-
Number of sells
-
82
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q3 2024
As of 30 Sep 2024,
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
142,604,810 shares.
The largest 10 holders included
UBS Group AG, VANGUARD GROUP INC, BlackRock, Inc., TPG GP A, LLC, Rubric Capital Management LP, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, NEUBERGER BERMAN GROUP LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
180
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.